Wealthy Pursue Scientific Longevity

The evolution of how wealthy individuals approach health and longevity has shifted from simple lifestyle modifications to sophisticated scientific interventions. Throughout history, the ultra-wealthy have been early adopters of health practices, but modern billionaires are taking it to new levels with scientific approaches and significant investments in longevity technology.

Key Points:

• Historical Wealthy Health Practices:

  • John Rockefeller was meticulous about food choices, eating slowly and consulting doctors about dietary decisions
  • Thomas Edison focused on light eating, avoiding overeating, and taking daily naps
  • Wealthy people have always been health-conscious, but now have more scientific tools at their disposal

• Modern Billionaire Approaches:

  • Sam Altman:

    • Invested $375M in Helion Energy and $180M of personal wealth in Retro Health
    • Takes metformin for longevity
    • Focuses on "simple stuff" - healthy eating, exercise, adequate sleep

  • Peter Thiel:

    • Views death acceptance as a "psychological defense mechanism"
    • Takes HGH (human growth hormone)
    • Explores parabiosis (young blood treatments)
    • Believes living forever is better than economic consequences of immortality

  • Larry Ellison:

    • Questions the fundamental nature of death
    • Finds death conceptually incomprehensible

• Brian Johnson's Blueprint:

  • Spends $2-3M annually on health optimization
  • Strictly follows plant-based diet and exercise regimen
  • Measures everything religiously
  • Created Rejuvenation Olympics website to track biological vs chronological age
  • Growing community following his methods on Reddit

• Emerging Trends:

  • Focus on blood sugar management through drugs like metformin
  • Measuring biological age vs chronological age
  • Growing interest in longevity drugs and treatments
  • Wealthy people's health practices often become mainstream later

• Impact:

  • Whatever billionaires do tends to become popular with general public
  • Access to these treatments remains limited for average people
  • Scientific validity of some approaches still uncertain